vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $208.0M, roughly 1.3× VIRTUS INVESTMENT PARTNERS, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 16.3% vs 0.7%, a 15.6% gap on every dollar of revenue. On growth, VIRTUS INVESTMENT PARTNERS, INC. posted the faster year-over-year revenue change (-10.9% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-74.1M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
HCM vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $208.0M |
| Net Profit | $2.0M | $33.9M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 19.1% |
| Net Margin | 0.7% | 16.3% |
| Revenue YoY | -16.5% | -10.9% |
| Net Profit YoY | -83.6% | -14.2% |
| EPS (diluted) | $0.00 | $5.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $208.0M | ||
| Q3 25 | — | $216.4M | ||
| Q2 25 | $277.7M | $210.5M | ||
| Q1 25 | $324.5M | $217.9M | ||
| Q4 24 | — | $233.5M | ||
| Q3 24 | — | $227.0M | ||
| Q2 24 | $305.7M | $224.4M | ||
| Q1 24 | — | $222.0M |
| Q4 25 | $2.0M | $33.9M | ||
| Q3 25 | — | $31.3M | ||
| Q2 25 | $455.0M | $42.7M | ||
| Q1 25 | $11.9M | $28.1M | ||
| Q4 24 | — | $39.5M | ||
| Q3 24 | — | $49.1M | ||
| Q2 24 | $25.8M | $26.0M | ||
| Q1 24 | — | $37.9M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | 19.1% | ||
| Q3 25 | — | 21.7% | ||
| Q2 25 | -1.3% | 21.5% | ||
| Q1 25 | -5.0% | 16.8% | ||
| Q4 24 | — | 21.7% | ||
| Q3 24 | — | 24.3% | ||
| Q2 24 | -9.0% | 19.7% | ||
| Q1 24 | — | 14.5% |
| Q4 25 | 0.7% | 16.3% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | 163.8% | 20.3% | ||
| Q1 25 | 3.7% | 12.9% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 21.6% | ||
| Q2 24 | 8.4% | 11.6% | ||
| Q1 24 | — | 17.1% |
| Q4 25 | $0.00 | $5.15 | ||
| Q3 25 | — | $4.65 | ||
| Q2 25 | $0.52 | $6.12 | ||
| Q1 25 | $0.01 | $4.05 | ||
| Q4 24 | — | $4.65 | ||
| Q3 24 | — | $5.71 | ||
| Q2 24 | $0.03 | $2.43 | ||
| Q1 24 | — | $4.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | $390.0M |
| Stockholders' EquityBook value | $1.2B | $934.0M |
| Total Assets | $1.8B | $4.3B |
| Debt / EquityLower = less leverage | 0.08× | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $93.2M | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | $93.4M | $231.3M | ||
| Q1 25 | $82.8M | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | $82.1M | $247.6M | ||
| Q1 24 | — | $253.0M |
| Q4 25 | $1.2B | $934.0M | ||
| Q3 25 | — | $918.7M | ||
| Q2 25 | $1.2B | $896.4M | ||
| Q1 25 | $759.9M | $893.7M | ||
| Q4 24 | — | $897.5M | ||
| Q3 24 | — | $889.0M | ||
| Q2 24 | $740.1M | $868.7M | ||
| Q1 24 | — | $871.7M |
| Q4 25 | $1.8B | $4.3B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | $1.8B | $3.7B | ||
| Q1 25 | $1.3B | $3.7B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | $1.3B | $3.6B | ||
| Q1 24 | — | $3.5B |
| Q4 25 | 0.08× | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | 0.08× | 0.26× | ||
| Q1 25 | 0.11× | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | 0.11× | 0.29× | ||
| Q1 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-67.2M |
| Free Cash FlowOCF − Capex | $3.4M | $-74.1M |
| FCF MarginFCF / Revenue | 1.2% | -35.6% |
| Capex IntensityCapex / Revenue | 1.8% | 3.3% |
| Cash ConversionOCF / Net Profit | 4.21× | -1.99× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $100.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-67.2M | ||
| Q3 25 | — | $108.3M | ||
| Q2 25 | $-72.9M | $75.8M | ||
| Q1 25 | $40.3M | $-3.8M | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | — | $69.1M | ||
| Q2 24 | $-39.8M | $70.0M | ||
| Q1 24 | — | $-34.5M |
| Q4 25 | $3.4M | $-74.1M | ||
| Q3 25 | — | $106.9M | ||
| Q2 25 | $-82.2M | $74.2M | ||
| Q1 25 | $32.5M | $-6.8M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | — | $68.7M | ||
| Q2 24 | $-49.9M | $68.6M | ||
| Q1 24 | — | $-36.5M |
| Q4 25 | 1.2% | -35.6% | ||
| Q3 25 | — | 49.4% | ||
| Q2 25 | -29.6% | 35.2% | ||
| Q1 25 | 10.0% | -3.1% | ||
| Q4 24 | — | -1.6% | ||
| Q3 24 | — | 30.3% | ||
| Q2 24 | -16.3% | 30.6% | ||
| Q1 24 | — | -16.4% |
| Q4 25 | 1.8% | 3.3% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | 3.3% | 0.7% | ||
| Q1 25 | 2.4% | 1.4% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | 3.3% | 0.6% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | 4.21× | -1.99× | ||
| Q3 25 | — | 3.45× | ||
| Q2 25 | -0.16× | 1.77× | ||
| Q1 25 | 3.38× | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | -1.54× | 2.69× | ||
| Q1 24 | — | -0.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
VRTS
| Open End Funds | $68.9M | 33% |
| Retail Separate Accounts | $51.3M | 25% |
| Institutional Accounts | $39.6M | 19% |
| Administration And Shareholder Service Fees | $18.4M | 9% |
| Closed End Funds | $15.9M | 8% |
| Distribution And Service Fees | $12.3M | 6% |
